SupplySide MarketPlace 2012 Preview: A New Hunger-Control Approach
The company describes OEA as a newly discovered lipid mediator involved in the regulation of feeding.
Chemi Nutra (White Bear Lake, MN) will showcase PhosphoLean NOPE+EGCG, a novel, proprietary hunger-control ingredient whose mechanism of action involves oleoyl ethanolamide (OEA). The company describes OEA as a newly discovered lipid mediator involved in the regulation of feeding, and a natural compound responsible for signaling the brain to stop hunger sensations. “Thus,” the company says, “PhosphoLean NOPE+EGCG shuts down hunger, stops binge eating and diet stress, and reduces food intake-leading to long-term diet success and successful weight loss.” It says PhosphoLean NOPE+EGCG has been clinically proven to help dieters.
Chemi Nutra, Booth 630
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
Microalgae extract supports metabolic health and bone mass during diet and exercise routine
April 11th 2024The extract from Microphyt, called PhaeOptim, was shown to complement weight management strategies that include diet and exercise by support bone mass, aerobic capacity, resting heart rate, and blood lipid profiles.
